⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GMAB News
Genmab A/S ADS
Completion of Share Buy-back Program
globenewswire.com
GMAB
Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
globenewswire.com
GMAB
ABBV
Tivdak (Genmab, Pfizer: tisotumab vedotin-tftv) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
PFE
GMAB
Tivdak (Genmab, Pfizer: tisotumab vedotin-tftv) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
PFE
GMAB
Transactions in Connection with Share Buy-back Program
globenewswire.com
GMAB
Correction to Company Announcement No. 13 of March 2, 2026
globenewswire.com
GMAB
Correction to Company Announcement No. 13 of March 2, 2026
globenewswire.com
GMAB
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
globenewswire.com
GMAB
Transactions in Connection with Share Buy-back Program
globenewswire.com
GMAB
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
globenewswire.com
GMAB